AssayIndex
Reports by quarter

Reports submitted in 2026-Q3 · page 2

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.92 % area, n=453. Read the 2026-Q3 state-of-the-index report →

453 records12 pagesmedian on this page 98.90 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041385BPC-157WWBWWB-2606-H3906Medutest2026-Q399.314.31—Supplier-supplied1MARGINAL
AX-2026-042797SelankGGPepsGGPE-2602-G2056Medutest2026-Q398.467.92—Buyer-sourced0FAIL
AX-2026-042184IpamorelinHomopeptideHOMO-2608-A9045Kestrel2026-Q399.274.79103.2Supplier-supplied1MARGINAL
AX-2026-041734CJC-1295 with DACQSCQSC-2602-E9474Medutest2026-Q399.437.17105.5Supplier-supplied2FAIL
AX-2026-041454RetatrutideQYBQYB-2604-B5660Janoshik2026-Q398.842.77—Supplier-supplied1MARGINAL
AX-2026-042479Melanotan IISWBSWB-2603-A5707Janoshik2026-Q399.163.6794.5Supplier-supplied1MARGINAL
AX-2026-041538RetatrutideQYBQYB-2602-G6308Medutest2026-Q398.502.85—Supplier-supplied2MARGINAL
AX-2026-041456RetatrutideQYBQYB-2604-B5660Janoshik2026-Q398.233.24—Supplier-supplied1MARGINAL
AX-2026-041452RetatrutideQYBQYB-2604-B5660Nordanalyt2026-Q398.503.36—Supplier-supplied1MARGINAL
AX-2026-041427IpamorelinQYBQYB-2605-H4298Janoshik2026-Q399.934.12—Supplier-supplied0PASS
AX-2026-043503BPC-157BCHBCH-2603-G6422Janoshik2026-Q398.464.32—Supplier-supplied1MARGINAL
AX-2026-043108TirzepatideKPKP-2608-D5921Janoshik2026-Q399.705.45—Supplier-supplied2MARGINAL
AX-2026-041767SemaglutideFGPFGP-2602-M1508PeptideMeter2026-Q398.652.54—Supplier-supplied2FAIL
AX-2026-041390BPC-157WWBWWB-2606-H3906Medutest2026-Q399.474.8499.3Supplier-supplied1MARGINAL
AX-2026-043488PramlintideWXTWXT-2603-D6052Janoshik2026-Q397.874.37—Supplier-supplied1MARGINAL
AX-2026-042057SermorelinTFCTFC-2605-Y6440Janoshik2026-Q398.683.9498.3Supplier-supplied0PASS
AX-2026-041741TirzepatideFGPFGP-2603-L9714PeptideMeter2026-Q398.622.57—Supplier-supplied1MARGINAL
AX-2026-043575N-Acetyl Semax AmideBCHBCH-2602-E8253Janoshik2026-Q397.449.19104.8Supplier-supplied1FAIL
AX-2026-043289L-CarnosineCPCCPC-2603-G1651Janoshik2026-Q398.0110.52—Buyer-sourced1FAIL
AX-2026-042481Melanotan IISWBSWB-2603-A5707Medutest2026-Q398.953.3790.8Supplier-supplied1MARGINAL
AX-2026-042460Kisspeptin-10SWBSWB-2603-D6238Kestrel2026-Q399.554.2190.8Supplier-supplied3MARGINAL
AX-2026-041882SemaglutideJEEPJEEP-2607-X3911Nordanalyt2026-Q399.174.52—Supplier-supplied1MARGINAL
AX-2026-041845TB-500JEEPJEEP-2602-V3434Janoshik2026-Q399.724.04102.2Supplier-supplied1MARGINAL
AX-2026-041386BPC-157WWBWWB-2606-H3906VendorInvestigate2026-Q399.324.8899.2Buyer-sourced1MARGINAL
AX-2026-041335SemaglutideWWBWWB-2606-N3192Janoshik2026-Q399.554.55100.5Supplier-supplied1MARGINAL
AX-2026-041271LiraglutideWWBWWB-2607-X2189Medutest2026-Q399.935.2495.8Supplier-supplied0PASS
AX-2026-043539CJC-1295 with DACBCHBCH-2607-H7307Janoshik2026-Q398.125.78100.6Supplier-supplied1MARGINAL
AX-2026-043287L-CarnosineCPCCPC-2603-G1651Janoshik2026-Q398.359.8993.2Supplier-supplied2FAIL
AX-2026-042669CJC-1295 (no DAC)GGPepsGGPE-2606-E8495Medutest2026-Q398.614.0695.5Supplier-supplied0PASS
AX-2026-041488PT-141 (Bremelanotide)QYBQYB-2607-L5615Janoshik2026-Q399.933.79—Supplier-supplied0PASS
AX-2026-043039RetatrutideKPKP-2607-H5219Janoshik2026-Q396.145.62—Supplier-supplied2FAIL
AX-2026-042743SelankGGPepsGGPE-2603-J9708Medutest2026-Q399.599.37—Supplier-supplied0PASS
AX-2026-042665CJC-1295 (no DAC)GGPepsGGPE-2606-E8495Janoshik2026-Q398.444.0093.2Supplier-supplied1MARGINAL
AX-2026-042650Melanotan IIGGPepsGGPE-2603-P8735Medutest2026-Q399.866.49—Supplier-supplied3MARGINAL
AX-2026-042483Melanotan IISWBSWB-2603-A5707Janoshik2026-Q399.383.73107.2Supplier-supplied1MARGINAL
AX-2026-041459RetatrutideQYBQYB-2604-B5660VendorInvestigate2026-Q397.912.8492.2Buyer-sourced1MARGINAL
AX-2026-041328SemaglutideWWBWWB-2606-N3192Janoshik2026-Q399.484.59—Supplier-supplied1MARGINAL
AX-2026-043100TirzepatideKPKP-2608-D5921VendorInvestigate2026-Q398.275.3194.4Buyer-sourced2MARGINAL
AX-2026-042398SemaglutideSWBSWB-2602-X5278Nordanalyt2026-Q399.084.48—Supplier-supplied1MARGINAL
AX-2026-042274SLU-PP-332HomopeptideHOMO-2602-Y2822VendorInvestigate2026-Q398.714.72—Laboratory-retained0PASS